Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study-Reference-Cited by-同舟云学术

Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study

Published:2015-04 Issue:4 Volume:15 Page:429-438
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Ravimohan Shruthi,Tamuhla Neo,Steenhoff Andrew P,Letlhogile Rona,Nfanyana Kebatshabile,Bellamy Scarlett L,MacGregor Rob Roy,Gross Robert,Weissman Drew,Bisson Gregory P

Funder

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Penn Center for AIDS Research

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference38 articles.

1. Timing of initiation of antiretroviral drugs during tuberculosis therapy;Abdool Karim;N Engl J Med,2010

2. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis;Havlir;N Engl J Med,2011

3. Integration of antiretroviral therapy with tuberculosis treatment;Abdool Karim;N Engl J Med,2011

4. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis;Blanc;N Engl J Med,2011

5. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs;Luetkemeyer;J Acquir Immune Defic Syndr,2014

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression;ACS Infectious Diseases;2024-07-22

2. Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study;Frontiers in Immunology;2024-05-28

3. Food Insecurity and Undernutrition Are Associated With Distinct Immunologic Profiles in People With Tuberculosis and Advanced HIV Starting Antiretroviral Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-04-15

4. Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial;Open Forum Infectious Diseases;2024-01-22

5. Cytokine storm in COVID-19 and malaria: Annals of pro-inflammatory cytokines;Cytokine;2024-01